Browse > Article

Effect of $\beta_2$-GP1 on the Binding of Anti-cardiolipin Antibodies to Cardiolipin  

Kang, Eun-Young (Laboratory of Immunology, Institute for Medical Sciences, Ajou University Schools of Medicine)
Jang, Young-Ju (Laboratory of Immunology, Institute for Medical Sciences, Ajou University Schools of Medicine)
Publication Information
IMMUNE NETWORK / v.4, no.3, 2004 , pp. 161-165 More about this Journal
Abstract
Background: Anti-cardiolipin antibody (Anti-CL Ab) is one of the various antiphospholipid antibodies (Anti-PL Abs) and found in the plasma of patients with systemic lupus erythematosus (SLE), atherosclerosis, and other infectious diseases. While anti-PL Abs found in the sera of patients with infectious diseases bind directly to CL, binding of anti-PL Abs to CL circulating in the sera of patients with autoimmune diseases is mediated by $\beta_2-$glycoprotein 1 ($\beta_2-GP1$). The purpose of this study is to investigate the effect of <$\beta_2-GP1$ on the antigen binding assay of anti-CL Abs present in the sera of patients with atherosclerosis, which has been known as one of autoimmune diseases. Methods: ELISA was performed with sera containing anti-CL Abs from three patients with atherosclerosis in the presence or absence of $\beta_2-GP1$ or FBS. Results: Reactivity of anti-CL Abs to CL was increased in the presence of $\beta_2-GP1$ or FBS in a dose dependent manner. Conclusion: <$\beta_2-GP1$ or FBS could be used as co-factor in CL ELISA with anti-CL Abs present in the sera of patients with atherosclerosis. It is suggested that anti-CL Abs found in atherosclerosis patients are similar in terms of antigen binding property to those circulating in the patients with autoimmune diseases, not to infectious diseases.
Keywords
Anti-CL; anti-PL; atherosclerosis; co-factor; $\beta_2$-GP1; FBS;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Thiagarajan P: Atherosclerosis, autoimmunity, and systemic lupus erythematosus. Circulation 104(16);1876-1877, 2001   PUBMED
2 Vaarala O: Antiphospholipid antibodies and myocardial infarction. Lupus 7 Suppl 2;S132-134, 1998   DOI   PUBMED   ScienceOn
3 Matsuura E, Igarashi Y, Yasuda T, Triplett DA, Koike T: Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 179(2);457-462, 1994   DOI   ScienceOn
4 Matsuura E, Igarashi Y, Yasuda T, Triplett DA, Koike T: Anticardiolipin antibodies recognize $\beta$$_2$-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 179(2);457-462, 1994   DOI   ScienceOn
5 Wick G, Perschinka H, Xu Q: Autoimmunity and atherosclerosis. Am Heart J 138(5 Pt 2);S444-449, 1999   DOI   ScienceOn
6 Nityanand S, Bergmark C, de Faire U, Swedenborg J, Holm G, Lefvert AK: Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease. J Intern Med 238(5);437-443, 1995   DOI   ScienceOn
7 Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RF: Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 66(6);629-632, 1991
8 Vaarala O: Autoantibodies to modified LDLs and other phospholipid-protein complexes as markers of cardiovascular diseases. J Intern Med 247(3);381-384, 2000   DOI   PUBMED   ScienceOn
9 Pratico D, Tangirala RK, Horkko S, Witztum JL, Palinski W, FitzGerald GA: Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F(2alpha)-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E. Blood 97(2);459-464, 2001   DOI   ScienceOn
10 McNeil HP, Simpson RJ, Chesterman CN, Krilis SA: Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation:$\beta$$_2$-Glycoprotein I (apolipoprotein H). PNAS 87; 4120-4124, 1990   DOI   ScienceOn
11 Ichikawa K, Khamashta MA, Koike T, Matsuura E, Hughes GF: $\beta$$_2$-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. Arthritis Rheum 37(10);1453-1461, 1994   DOI   ScienceOn
12 Wick G, Perschinka H, Millonig G: Atherosclerosis as an autoimmune disease: an update. Trends Immunol 22(12); 665-669, 2001   DOI   ScienceOn